Entera Bio Ltd

詳細情報 Entera Bio Ltd 企業名

Entera Bio Ltd is an Israel-based clinical-stage biopharmaceutical company focused on the development and commercialization of orally delivered large molecule therapeutics for use in areas with unmet medical need and where adoption of injectable therapies is limited due to cost, convenience and compliance challenges for patients. The Company developed a platform that enables the oral delivery of injectable proteins and large molecules. Entera Bio candidates are EB613 for the treatment of osteoporosis and EB612 for the treatment of hypoparathyroidism. Both EB613 and EB612 are oral formulations of human parathyroid hormone (1-34), or Parathormon (PTH). The products are administered via injection.

企業情報

企業コードENTX

会社名Entera Bio Ltd

上場日Jun 28, 2018

最高経営責任者「CEO」Ms. Miranda Jayne Toledano

従業員数18

証券種類Ordinary Share

決算期末Jun 28

本社所在地Hadassah / Jerusalem Bio

都市JERUSALEM

証券取引所NASDAQ Capital Market Consolidated

国Israel

郵便番号9112002

電話番号97225327151

ウェブサイトhttps://enterabio.com/

企業コードENTX

上場日Jun 28, 2018

最高経営責任者「CEO」Ms. Miranda Jayne Toledano

役員一覧

会社名

会社名/ポジション

ポジション

株式保有

変動額

Mr. Gerald M. (Jerry) Lieberman

Independent Chairman of the Board

324.96K

--

Ms. Miranda Jayne Toledano

Chief Executive Officer, Director

291.45K

+163.16%

Mr. Sean Ellis

Independent Director

134.73K

--

Ms. Haya Taitel

Independent Director

64.65K

--

Mr. Yonatan Malca

Independent Director

47.26K

--

Mr. Gerald M. (Jerry) Ostrov

Independent Director

46.94K

--

Mr. Ron Abraham Mayron

Independent Director

--

Ms. Dana Yaacov-Garbeli

Chief Financial Officer

--

Dr. Roger J. Garceau, M.D.

Director

--

Dr. Hillel Galitzer

Chief Operating Officer

--

詳細を見る

会社名

会社名/ポジション

ポジション

株式保有

変動額

Mr. Gerald M. (Jerry) Lieberman

Independent Chairman of the Board

324.96K

--

Ms. Miranda Jayne Toledano

Chief Executive Officer, Director

291.45K

+163.16%

Mr. Sean Ellis

Independent Director

134.73K

--

Ms. Haya Taitel

Independent Director

64.65K

--

Mr. Yonatan Malca

Independent Director

47.26K

--

Mr. Gerald M. (Jerry) Ostrov

Independent Director

46.94K

--

収益内訳

データなし

データなし

事業別

地域別

データなし

株主

更新時刻: Thu, Jul 17

株主統計

種類

株主統計

比率

Knoll Capital Management, LLC

12.94%

OPKO Health Inc

8.50%

D.N.A Biomedical Solutions, Ltd.

8.21%

Point72 Asset Management, L.P.

5.93%

Centillion Fund Inc

5.27%

Other

59.14%

株主統計

比率

Knoll Capital Management, LLC

12.94%

OPKO Health Inc

8.50%

D.N.A Biomedical Solutions, Ltd.

8.21%

Point72 Asset Management, L.P.

5.93%

Centillion Fund Inc

5.27%

Other

59.14%

種類

株主統計

比率

Corporation

21.99%

Hedge Fund

21.33%

Individual Investor

2.44%

Investment Advisor

0.70%

Research Firm

0.07%

Investment Advisor/Hedge Fund

0.05%

Venture Capital

0.02%

Other

53.41%

機関投資家保有株

更新時刻: Tue, Jul 1

報告期間

機関投資家数

保有株式数

比率

変動額

2025Q2

44

20.97M

46.14%

-173.92K

2025Q1

48

20.87M

47.30%

+2.99M

2024Q4

45

14.59M

39.63%

+276.18K

2024Q3

44

12.66M

34.61%

+129.89K

2024Q2

43

12.40M

34.23%

+1.30M

2024Q1

39

11.33M

31.94%

+147.25K

2023Q4

38

10.84M

34.31%

+2.50M

2023Q3

40

9.31M

32.31%

-70.93K

2023Q2

42

9.22M

32.01%

-186.20K

2023Q1

42

9.45M

32.81%

-129.12K

詳細を見る

株主動向

会社名

保有株式数

比率

変動額

変動率

日付

Knoll Capital Management, LLC

5.88M

12.94%

--

Mar 31, 2025

OPKO Health Inc

3.87M

8.5%

+180.00K

+4.88%

May 08, 2025

D.N.A Biomedical Solutions, Ltd.

3.73M

8.21%

--

May 08, 2025

Point72 Asset Management, L.P.

2.70M

5.93%

-4.32K

-0.16%

Mar 31, 2025

Centillion Fund Inc

2.40M

5.27%

--

May 08, 2025

Schonfeld Strategic Advisors LLC

599.16K

1.32%

-33.16K

-5.24%

Mar 31, 2025

Parkman Healthcare Partners LLC

439.63K

0.97%

+25.90K

+6.26%

Mar 31, 2025

Lieberman (Gerald M)

324.96K

0.71%

--

May 08, 2025

Toledano (Miranda Jayne)

110.75K

0.24%

--

May 08, 2025

Northern Trust Global Investments Limited

198.83K

0.44%

-13.65K

-6.42%

Mar 31, 2025

詳細を見る

2.065USD

Entera Bio Ltd

2.065

概要

企業名

金融